FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

INDO US BIO-TECH LTD.

NSE : INDOUSBSE : 541304ISIN CODE : INE250Z01010Industry : AgricultureHouse : Private

BSE173.255.25 (+3.13 %)

PREV CLOSE (Rs.) 168.00

OPEN PRICE (Rs.) 173.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 255

TODAY'S LOW / HIGH (Rs.)162.20 173.95

52 WK LOW / HIGH (Rs.)147.25 386

NSE171.00-0.71 (-0.41 %)

PREV CLOSE( Rs. ) 171.71

OPEN PRICE (Rs.) 179.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4053

TODAY'S LOW / HIGH(Rs.) 164.30 179.00

52 WK LOW / HIGH (Rs.)145 388.4

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

0.43

Dividend Yield(%)

0.00

TTM EPS (Rs.)

6.54

P/E Ratio

26.50

Book Value (Rs.)

37.56

Face Value (Rs.)

MCap (Rs. in Mn)

3474.01

Price/Earning (TTM)

25.10

Price/Sales (TTM)

4.03

Price/Book (MRQ)

4.61

PAT Margin (%)

11.33

ROCE (%)

14.42

Incorporation Year : 04-02 2004

Management Info :

- Chairman Jagdish Ajudia - Managing Director

Registered Office :

Address : 309, Shanti Mall, Satadhar Char Rasta,Opp. Navrang Tower,Sola Road ,
Ahmedabad,
Gujarat-380061

Phone : 079 2749 1807 / 9909043999

Email : indous_jagdish@yahoo.co.in

Website : www.indousagriseeds.com

Registrars Details :

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

11Sep Indo US Bio-Tech informs about certifi
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

21Jun Indo Us Bio-Tech informs about clarifi
Indo Us Bio-Tech has informed regarding error in standalone financial re..

24Apr Indo Us Bio-Tech informs about disclos
Indo Us Bio-Tech has informed that the Company does not fulfill any of t..

Financials

	QTR Dec 24	ANNUAL 24
Net Profit	50.55	82.5099999999999
Gross Profit	50.18	88.0399999999999
Operating Profit	55.6	111.15
Net Sales	235.64	728.36

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Venkys India (BSE)

1709.80 (0.55%)

M.Cap (Rs. in Cr)2408.65

Nath Bio-Genes (BSE)

168.10 (3.57%)

M.Cap (Rs. in Cr)319.46

Genomic Valley (BSE)

63.13 (1.66%)

M.Cap (Rs. in Cr)19.28

Tierra Agrotech (BSE)

43.81 (1.88%)

M.Cap (Rs. in Cr)287.37

Shareholding Pattern

	PROMOTERS	70.17%
	NON-INSTITUTION	29.83%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

No Data Found

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22